As the Director of Safety Pharmacology for IMAPill Inc, you’…
As the Director of Safety Pharmacology for IMAPill Inc, you’re tasked with evaluating a new drug candidate for CNS evaluation. A. In designing your experiments, describe what doses you would select and experimental structure. Please design your experiment, including group number, dosages (no numbers), and rationale for each dosing group. B. Describe 3 Nervous System Safety Assessments (2 Core, 1 Follow-Up) and how animals would be evaluated in each assessment.